000			02152 a2200613 4500
005			20250517124237.0
264		0	_c20180205
008			201802s 0 0 eng d
022			_a1949-2553
024	7		_a10.18632/oncotarget.13272 _2doi
040			_aNLM _beng _cNLM
100	1		_aYang, Haopeng
245	0	0	_aBisdemethoxycurcumin exerts pro-apoptotic effects in human pancreatic adenocarcinoma cells through mitochondrial dysfunction and a GRP78-dependent pathway. _h[electronic resource]
260			_bOncotarget _cDec 2016
300			_a83641-83656 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAdenocarcinoma _xdrug therapy
650	0	4	_aAntimetabolites, Antineoplastic _xpharmacology
650	0	4	_aAntineoplastic Agents _xpharmacology
650	0	4	_aApoptosis _xdrug effects
650	0	4	_aCell Line, Tumor
650	0	4	_aCurcumin _xanalogs & derivatives
650	0	4	_aDeoxycytidine _xanalogs & derivatives
650	0	4	_aDiarylheptanoids
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aDrug Resistance, Neoplasm _xdrug effects
650	0	4	_aEndoplasmic Reticulum Chaperone BiP
650	0	4	_aEukaryotic Initiation Factor-2 _xmetabolism
650	0	4	_aHeat-Shock Proteins _xgenetics
650	0	4	_aHumans
650	0	4	_aMitochondria _xdrug effects
650	0	4	_aPancreatic Neoplasms _xdrug therapy
650	0	4	_aProhibitins
650	0	4	_aProtein Deglycase DJ-1 _xmetabolism
650	0	4	_aProtein Interaction Maps
650	0	4	_aRNA Interference
650	0	4	_aRepressor Proteins _xmetabolism
650	0	4	_aSignal Transduction _xdrug effects
650	0	4	_aTranscription Factor CHOP _xmetabolism
650	0	4	_aTransfection
650	0	4	_aGemcitabine
700	1		_aFan, Shengjun
700	1		_aAn, Yu
700	1		_aWang, Xin
700	1		_aPan, Yan
700	1		_aXiaokaiti, Yilixiati
700	1		_aDuan, Jianhui
700	1		_aLi, Xin
700	1		_aTie, Lu
700	1		_aYe, Min
700	1		_aLi, Xuejun
773	0		_tOncotarget _gvol. 7 _gno. 50 _gp. 83641-83656
856	4	0	_uhttps://doi.org/10.18632/oncotarget.13272 _zAvailable from publisher's website
999			_c26605355 _d26605355